Gene · 5422
Papers4,157
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 4,157
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mechanistic investigation of human maturation of Okazaki fragments reveals slow kinetics. | Nat Commun | 2022 | 36379932 | PubTator, text mining | PubMed |
| Experimental and In Silico Analysis of TEM β-Lactamase Adaptive Evolution. | ACS Infect Dis | 2022 | 36377311 | PubTator, text mining | PubMed |
| Systematic proximal mapping of the classical RAD51 paralogs unravel functionally and clinically relevant interactors for genome stability. | PLoS Genet | 2022 | 36374936 | PubTator, text mining | PubMed |
| Vitamin C Maintenance against Cell Growth Arrest and Reactive Oxygen Species Accumulation in the Presence of Redox Molecular Chaperone hslO Gene. | Int J Mol Sci | 2022 | 36361576 | PubTator, text mining | PubMed |
| Biogenic Amine Levels Markedly Increase in the Aqueous Humor of Individuals with Controlled Type 2 Diabetes. | Int J Mol Sci | 2022 | 36361545 | PubTator, text mining | PubMed |
| POLDIP3: At the Crossroad of RNA and DNA Metabolism. | Genes (Basel) | 2022 | 36360158 | PubTator, text mining | PubMed |
| Exploiting DNA Replication Stress as a Therapeutic Strategy for Breast Cancer. | Biomedicines | 2022 | 36359297 | PubTator, text mining | PubMed |
| Partial loss-of-function mutations in GINS4 lead to NK cell deficiency with neutropenia. | JCI Insight | 2022 | 36345943 | PubTator, text mining | PubMed |
| Processes in DNA damage response from a whole-cell multi-omics perspective. | iScience | 2022 | 36339253 | PubTator, text mining | PubMed |
| [Primary hypothyroidism and postmenopause as the causes of delayed diagnosis of panhypopituitarism in a patient with nonfunctional pituitary adenoma]. | Probl Endokrinol (Mosk) | 2022 | 36337016 | PubTator, text mining | PubMed |
| Laboratory diagnostics for human Leishmania infections: a polymerase chain reaction-focussed review of detection and identification methods. | Parasit Vectors | 2022 | 36335408 | PubTator, text mining | PubMed |
| Discovering a trans-omics biomarker signature that predisposes high risk diabetic patients to diabetic kidney disease. | NPJ Digit Med | 2022 | 36323795 | PubTator, text mining | PubMed |
| Determining the temporal, dose, and composition effects of nutritional substrates in an in vitro model of intrahepatocellular triglyceride accumulation. | Physiol Rep | 2022 | 36301719 | PubTator, text mining | PubMed |
| New Insights into SARS-CoV-2 and Cancer Cross-Talk: Does a Novel Oncogenesis Driver Emerge? | Vaccines (Basel) | 2022 | 36298472 | PubTator, text mining | PubMed |
Proposition of a New POLA Index to Assess the Immunomodulatory Properties of the Diet and Its Relationship with the Gut Microbiota, Using the Example of the Incidence of COVID-19 in a Group of People without Comorbidities. | Nutrients | 2022 | 36296911 | PubTator, text mining | PubMed |
| A Marked Low-Grade Inflammation and a Significant Deterioration in Metabolic Status in First-Episode Schizophrenia: A Five-Year Follow-Up Study. | Metabolites | 2022 | 36295885 | PubTator, text mining | PubMed |
| Two Ligand-Binding Sites on SARS-CoV-2 Non-Structural Protein 1 Revealed by Fragment-Based X-ray Screening. | Int J Mol Sci | 2022 | 36293303 | PubTator, text mining | PubMed |
| A Systematic Review on Suitability of Molecular Techniques for Diagnosis and Research into Infectious Diseases of Concern in Resource-Limited Settings. | Curr Issues Mol Biol | 2022 | 36286015 | PubTator, text mining | PubMed |
| The Percutaneous Endoscopic Lumbar Debridement and Irrigation Drainage Technique for the First-Stage Treatment of Spontaneous Lumbar Spondylodiscitis: A Clinical Retrospective Study. | Oxid Med Cell Longev | 2022 | 36285299 | PubTator, text mining | PubMed |
| Replication Protein A Utilizes Differential Engagement of Its DNA-Binding Domains to Bind Biologically Relevant ssDNAs in Diverse Binding Modes. | Biochemistry | 2022 | 36278947 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5422/papers?page=19